Two of these studies reported that CTLA-4 blockade during SIV vaccination after established infection resulted in higher viral loads, decreased responsiveness to anti-retroviral therapy, or increased anti-retroviral drug toxicity; however, both of these studies used modified vaccinia Ankara-based SIV vaccines [53,90]. This evidence concerns the gene CTLA4 and infection.